Heart failure trials recruiting in New York

All Heart failure trials nationally

Cities in New York

Recruiting trials in New York

• A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
  NCT03394365 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · New York: New York, The Bronx
• A Preliminary Study for INFORMED
  NCT05585125 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · New York: New York
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
  NCT05489705 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Cooperstown, New York, Roslyn, Valhalla
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
  NCT06979362 · Phase: Phase 2 · Ages: 40 Years to 84 Years · Sex: All (male and female) · New York: New York
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Brooklyn, New York, Rochester
• A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
  NCT07219511 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · New York: Buffalo
• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · New York: New York
• A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
  NCT06008197 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Roslyn, Stony Brook
• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn, Buffalo, New York, Rosedale
• A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07192952 · Phase: Phase 3 · Ages: Up to 18 Years · Sex: All (male and female) · New York: New York, The Bronx
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07188805 · Phase: Phase 3 · Ages: 6 Months to 17 Years · Sex: All (male and female) · New York: New York, The Bronx
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, The Bronx
• AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
  NCT06699056 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
  NCT06793371 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · New York: New York
• AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
  NCT06378632 · Phase: Not specified · Ages: 22 Years and older · Sex: All (male and female) · New York: New York, Roslyn
• ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
  NCT07559903 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Roslyn
• Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
  NCT06932081 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Alleviant ALLAY-HF Study
  NCT05685303 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · New York: New York, Roslyn, Stony Brook
• Alleviant ALLAY-HFrEF Study
  NCT06812533 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Rochester
• Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
  NCT06655376 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo, New York, Poughkeepsie
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Manhasset, New York, Rosedale, The Bronx
• CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
  NCT05996328 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · New York: New York
• Cardiogenic Shock Working Group Registry
  NCT04682483 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Cardiovascular Multimodality Imaging Study
  NCT06610019 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Brooklyn, College Point, Mineola
• Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
  NCT06964464 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn, Rochester
• DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs
  NCT07419360 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany
• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
  NCT05677100 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · New York: Brooklyn, New York, Poughkeepsie, Staten Island
• Echocardiographic Assessment of the Effect of Impella on Biventricular Function
  NCT07534462 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
  NCT01790152 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · New York: Buffalo, New Hyde Park, Rochester, Stony Brook
• Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
  NCT05714085 · Phase: Phase 2, Phase 3 · Ages: 29 Days to 17 Years · Sex: All (male and female) · New York: New York, The Bronx
• Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
  NCT04592445 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · New York: New York, Rochester
• Enhanced Nutritional Optimization in LVAD Trial
  NCT05655910 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
  NCT06898515 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · New York: Stony Brook
• His-Bundle Corrective Pacing in Heart Failure
  NCT05265520 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Hospital Airway Resuscitation Trial
  NCT05520762 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
  NCT07335510 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Impella Reverse Remodeling in End-Stage Heart Failure
  NCT06800716 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment
  NCT07220798 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 101 Years · Sex: All (male and female) · New York: New York
• Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
  NCT06118983 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Incretin Therapies in Obesity-related HFpEF
  NCT07554638 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
  NCT07490054 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
  NCT06310031 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · New York: New York, The Bronx
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
  NCT07288398 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: New York, Rochester
• Left vs Left Randomized Clinical Trial
  NCT05650658 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Albany, New York, Poughkeepsie, Staten Island
• MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
  NCT07349797 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
  NCT06080074 · Phase: Phase 2 · Ages: 0 Years to 16 Years · Sex: All (male and female) · New York: New York
• NORM-HF Pivotal Study
  NCT07574593 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
  NCT06311708 · Phase: Not specified · Ages: 14 Years to 65 Years · Sex: All (male and female) · New York: New York
• Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
  NCT06228924 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
  NCT06532890 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · New York: New York
• Optimizing HFrEF Patients Using BaroStim and CardioMems
  NCT07399587 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: Riverhead
• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
  NCT05934487 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Stony Brook
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · New York: Albany, Brooklyn, Massapequa, New York
• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  NCT00271180 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · New York: Huntington, Manhasset, New York, Port Jefferson
• Quantifying New Heart Muscle Cells
  NCT06587165 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Days to 1 Year · Sex: All (male and female) · New York: New York
• REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
  NCT06777368 · Phase: Not specified · Ages: 18 Years to 105 Years · Sex: All (male and female) · New York: Buffalo, Manhasset, New York, Roslyn
• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
  NCT06360380 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 79 Years · Sex: All (male and female) · New York: New York, Rochester
• Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
  NCT07069738 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Flushing, New York, Syracuse
• Simulation Trial of Telemedical Support for Paramedics
  NCT06441760 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · New York: Buffalo
• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
  NCT06217302 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Syracuse, The Bronx
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · New York: Buffalo, Manhasset, New York
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: Albany, Manhasset, New York, The Bronx
• Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
  NCT06597019 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · New York: New York
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · New York: Albany, Brooklyn, Clifton Park, Manhasset
• TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
  NCT06137807 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Manhasset, The Bronx
• The CardioClip Study
  NCT06241430 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · New York: New York
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
  NCT03142152 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Buffalo, New York, Poughkeepsie
• The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
  NCT07098858 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · New York: New York
• Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
  NCT06228209 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
  NCT07221851 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · New York: Lake Success
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Manhasset, New York, Rochester, The Bronx
• Use of ReDS Technology in Patients With Acute Heart Failure
  NCT04305717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
  NCT07079735 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: New York
• Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
  NCT05459233 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Syracuse
• XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
  NCT06895070 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York